Patient satisfaction with telemedicine for substance-related disorders

被引:0
作者
Farias, Maria Alejandra [1 ]
Badino, Manuel [2 ]
de Apocada, Maria Jose Fuster [3 ]
机构
[1] Univ Nacl Educ Distancia IMIENS, Programa Doctorado Ciencias Biomed & Salud Publ, Madrid 28040, Spain
[2] Univ Nacl Cordoba, Escuela Salud Publ, Cordoba, Argentina
[3] Univ Nacl Educ Distancia, Fac Psicol, Madrid, Spain
来源
DIGITAL HEALTH | 2024年 / 10卷
关键词
Telemedicine; patient satisfaction; substance-related disorders; health services accessibility-quality-of-life; EXPERIENCES; SERVICES;
D O I
10.1177/20552076241240974
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction Telemedicine has been shown to be an effective approach for people with substance-related disorders. Analyzing patient satisfaction with telemedicine is necessary for improving treatment outcomes. This study aims to assess patient satisfaction with telemedicine for substance-related disorders at the Centro Asistencial C & oacute;rdoba in Argentina.Methods A cross-sectional, descriptive, and correlational design was carried out. A patient satisfaction survey was created, consisting of eight questions and a quality-of-life question, which was administered to N = 115 patients.Results The results showed that more than 90% agreed with the ease of use of virtual consultations, 82% felt they received the same level of care as if the consultation had been in person, 86% agreed with the adequacy of time utilized during the virtual session, and over 85% agreed to repeat their telemedicine treatment. Regarding the composite variable "users' assessment of telemedicine," we found an average of 17.41 +/- 2.80. Concerning satisfaction with virtual care and the previous use of telemedicine, 95.7% were satisfied, and nearly 61.7% reported not having used virtual care previously. In terms of money and time saved, 93.9% saved money with virtual consultations, 66.1% saved more than two hours per week, 23.5% saved more than one hour per week, and 10.4% saved less than one hour per week.Conclusions Overall, there is significant approval of telemedicine among users of substance-related disorders services. In particular, they were satisfied with the time employed, the benefits of saving time and money, and the ease of use of telemedicine; furthermore, they were positive about undergoing telemedicine treatment in the future.
引用
收藏
页数:7
相关论文
共 46 条
  • [1] A Review of Patient Satisfaction and Experience with Telemedicine: A Virtual Solution During and Beyond COVID-19 Pandemic
    Aashima
    Nanda, Mehak
    Sharma, Rajesh
    [J]. TELEMEDICINE AND E-HEALTH, 2021, 27 (12) : 1325 - 1331
  • [2] Utilization of Telemedicine during COVID-19 in Saudi Arabia: A Multicenter Study
    Al Mutair, Abbas
    Saha, Chandni
    Alhuqbani, Waad
    Alhuqbani, Mohammed N.
    AlQahtani, Mohammed N.
    Abogosh, Ahmad K.
    Alsedrah, Abdulaziz M.
    Alhindi, Alanoud H.
    Alfehaid, Reema H.
    Al-omari, Awad
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [3] [Anonymous], 2023, Telehealth for behavioral health care. In
  • [4] A Narrative Review of Telemedicine in Latin America during the COVID-19 Pandemic
    Camacho-Leon, Genesis
    Faytong-Haro, Marco
    Carrera, Keila
    Molero, Marlyn
    Melean, Franhe
    Reyes, Yuliana
    Mautong, Hans
    de la Hoz, Ivonne
    Cherrez-Ojeda, Ivan
    [J]. HEALTHCARE, 2022, 10 (08)
  • [5] Patient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine: Brief Literature Review and Development of a New Assessment
    Cole, Thomas O.
    Robinson, Darlene
    Kelley-Freeman, Andrea
    Gandhi, Devang
    Greenblatt, Aaron D.
    Weintraub, Eric
    Belcher, Annabelle M.
    [J]. FRONTIERS IN PUBLIC HEALTH, 2021, 8
  • [6] Addiction and COVID: Issues, Challenges, and New Telehealth Approaches
    Edinoff, Amber N.
    Kaufman, Sarah E.
    Chauncy, Tyler M.
    Erwin, Abigail P.
    Russo, Katherine M.
    Nelson, Meredith E.
    Cornett, Elyse M.
    Shah-Bruce, Mila
    Kaye, Adam M.
    Kaye, Alan D.
    Girardi, Paolo
    Adan, Ana
    [J]. PSYCHIATRY INTERNATIONAL, 2022, 3 (02): : 169 - 180
  • [7] The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting
    Eibl, Joseph K.
    Gauthier, Graham
    Pellegrini, David
    Daiter, Jeffery
    Varenbut, Michael
    Hogenbirk, John C.
    Marsh, David C.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2017, 176 : 133 - 138
  • [8] Telemedicine in the OECD: An umbrella review of clinical and cost-effectiveness, patient experience and implementation
    Eze, Nkiruka D.
    Mateus, Ceu
    Hashiguchi, Tiago Cravo Oliveira
    [J]. PLOS ONE, 2020, 15 (08):
  • [9] Telehealth Benefits and Barriers
    Gajarawala, Shilpa N.
    Pelkowski, Jessica N.
    [J]. JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2021, 17 (02): : 218 - 221
  • [10] Garc?a-Huidobro N.F., 2020, REV OTORRINOLAR CIR, V80, P403, DOI [10.4067/s0718-48162020000400403, DOI 10.4067/S0718-48162020000400403]